Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo.
暂无分享,去创建一个
[1] N. Harada,et al. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] B. Cornelissen,et al. 123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[3] Veerle Kersemans,et al. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] G. Reifenberger,et al. Evaluation of new 18F-labeled amino acids for brain PET , 2005, Anatomy and Embryology.
[5] H. Herzog,et al. Preferred Stereoselective Transport of the D-isomer of cis-4-[18F]fluoro-proline at the Blood–Brain Barrier , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] M. Palacín,et al. Identification of LAT4, a Novel Amino Acid Transporter with System L Activity* , 2005, Journal of Biological Chemistry.
[7] Veerle Kersemans,et al. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] Emilija Veljkovic,et al. SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] G. Slegers,et al. Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT. , 2004, Nuclear medicine and biology.
[10] S. Bröer,et al. Molecular Cloning of Mouse Amino Acid Transport System B0, a Neutral Amino Acid Transporter Related to Hartnup Disorder* , 2004, Journal of Biological Chemistry.
[11] E. Babu,et al. Identification of a Novel System L Amino Acid Transporter Structurally Distinct from Heterodimeric Amino Acid Transporters* , 2003, Journal of Biological Chemistry.
[12] Axel Bossuyt,et al. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] E. Babu,et al. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. , 2002, Biochimica et biophysica acta.
[14] C. Meier,et al. Activation of system L heterodimeric amino acid exchangers by intracellular substrates , 2002, The EMBO journal.
[15] Y. Kanai,et al. Expression of L‐type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in liver tumor lesions of rat models , 2001, Journal of surgical oncology.
[16] Y. Kanai,et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. , 2001, Biochimica et biophysica acta.
[17] N. Thompson,et al. Overexpression of LAT1/CD98 Light Chain Is Sufficient to Increase System l-Amino Acid Transport Activity in Mouse Hepatocytes but Not Fibroblasts* , 2001, The Journal of Biological Chemistry.
[18] A. Bossuyt,et al. In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport. , 2001, Nuclear medicine and biology.
[19] V. Ganapathy,et al. Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine. , 2000, Biochimica et biophysica acta.
[20] M. Schwaiger,et al. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] Eiji Takeda,et al. Identification and Functional Characterization of a Na+-independent Neutral Amino Acid Transporter with Broad Substrate Selectivity* , 1999, The Journal of Biological Chemistry.
[22] Eiji Takeda,et al. Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)* , 1998, The Journal of Biological Chemistry.
[23] G. Digenis,et al. Biological evaluation of radiolabeled D-methionine as a parent compound in potential nuclear imaging. , 1984, Radioisotopes.
[24] T. Suzuki,et al. Characteristics of D-leucine uptake by mouse Ehrlich ascites tumor cells. , 1979, Journal of biochemistry.
[25] T. Suzuki,et al. Preferential incorporation of some 14C-labeled D-amino acids into tumor-bearing animals. , 1978, Gan.
[26] Veerle Kersemans,et al. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine. , 2006, Nuclear medicine and biology.
[27] M. Bergström,et al. The normal pituitary examined with positron emission tomography and (methyl-11C)-L-methionine and (methyl-11C)-D-methionine , 2004, Neuroradiology.
[28] O. Schober,et al. Uptake of 11C-l-and d-methionine in brain tumors , 2004, European Journal of Nuclear Medicine.
[29] R T Borchardt,et al. Derivatives of melphalan designed to enhance drug accumulation in cancer cells. , 1997, Journal of drug targeting.
[30] A. Bockisch,et al. Imaging of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine and SPECT , 1989 .